Suzhou Yumed Pharmaceutical Technology Co., Ltd. (referred to as "Yumed Pharmaceutical"), established in 2021, is a CDMO supplier that specializes in providing one-stop services for small molecule drug customers from route development to commercialization, including research and development, production, and registration application. Its business covers laboratory customization; Process development; Intermediate and API pilot production, product sales, commercial production, etc

Yumed Pharmaceutical actively promotes the construction of an innovative talent team, with over 50 employees, over 50% of whom hold graduate degrees or above. The core R&D management team members have an average of over 10 years of experience in the pharmaceutical industry, and have vertical integration capabilities in the development and production of small molecule drugs. They are skilled in customized synthesis, process development, raw material production, and commercial production of intermediates for various types of small molecule drugs.